Wolf's Substack

Wolf's Substack

Share this post

Wolf's Substack
Wolf's Substack
Medexus Pharma ($MDP.TO) FINS Review
FINS Reviews

Medexus Pharma ($MDP.TO) FINS Review

2024 Annual Filings

Wolf Of Oakville's avatar
Wolf Of Oakville
Jul 03, 2025
∙ Paid
6

Share this post

Wolf's Substack
Wolf's Substack
Medexus Pharma ($MDP.TO) FINS Review
Share

First review of MDP via a rather popular request out of the Wolf Den discord for this $101M market cap pharma play trading on the TSX.

Over a one year time frame the stock has performed admirably, up 71%, but if you bought during that early year FOMO run, or participated in their January raise you could be holding some decent sized bags on this one.

Medexus dropped their 2024 annuals last week and the market appears to have had a rather muted reaction, trading down about 7% since. Let’s get into it.

Wolf of Oakville is a Substack Best Seller producing both free and premium paid content for over 3400 subscribers


This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Wolf
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share